4//SEC Filing
Vasista Vittal 4
Accession 0001562180-22-000597
CIK 0001590877other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:25 PM ET
Size
8.2 KB
Accession
0001562180-22-000597
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Vasista Vittal
See Remarks
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-01-20−29,900→ 35,000 totalExercise: $0.85Exp: 2024-09-23→ Common Stock (29,900 underlying) - Exercise/Conversion
Common Stock
2022-01-20$0.85/sh+29,900$25,415→ 162,440 total
Footnotes (2)
- [F1]The previously granted option, representing a right to purchase a total of 424,900 shares, became exercisable as follows: 284,683 of the shares subject to the option are initial shares ("Initial Shares") and 140,217 of the shares subject to the option are contingent shares ("Contingent Shares"). 72,235 of the Initial Shares vested on September 17, 2014, 53,112 of the Initial Shares vested on September 17, 2015 and an additional 4,426 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.
- [F2](Continued from footnote 1) Notwithstanding the foregoing, 59,533 shares subject to this option that would otherwise have vested monthly between January 2018 and September 2018 were deemed vested as of December 31, 2015 on January 28, 2016 due to subsequent events.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001652827
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:25 PM ET
- Size
- 8.2 KB